Rapacuronium

Drug profile

Key facts

Rapacuronium is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1999. DrugCentral lists 1 molecular target, including CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND. Recorded indications include General anesthesia, Muscle relaxation, function, Skeletal Muscle Relaxation for Endotracheal Intubation and Skeletal Muscle Relaxation for Endotracheal Intubation in C-Section.

• Approval status: ofm (first approved 1999 by the FDA).
• Molecular targets: CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND (1 listed in DrugCentral).
• Indications: General anesthesia, Muscle relaxation, function, Skeletal Muscle Relaxation for Endotracheal Intubation and Skeletal Muscle Relaxation for Endotracheal Intubation in C-Section.
• Molecular formula: C37H61N2O4+; molecular weight 597.90 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (4)

• General anesthesia
• Muscle relaxation, function
• Skeletal Muscle Relaxation for Endotracheal Intubation
• Skeletal Muscle Relaxation for Endotracheal Intubation in C-Section

Contraindications (3)

• Disease of liver
• Eaton-Lambert syndrome
• Myasthenia gravis

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Muscle-type nicotinic acetylcholine receptor	CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND	antagonist	—

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1999-08-18	FDA	—	ORGANON USA INC

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Rapacuronium is on its molecule page.

• Molecular formula: C₃₇H₆₁N₂O₄+
• Molecular weight: 597.90 g/mol
• CAS number: —
• InChIKey: HTIKWNNIPGXLGM-YLINKJIISA-N
• PubChem CID: 5311399

CCC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Rapacuronium used for?

DrugCentral lists the following indications for Rapacuronium: General anesthesia, Muscle relaxation, function, Skeletal Muscle Relaxation for Endotracheal Intubation and Skeletal Muscle Relaxation for Endotracheal Intubation in C-Section.

How does Rapacuronium work?

Its molecular targets in DrugCentral include CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND (antagonist).

When was Rapacuronium first approved?

Rapacuronium was first approved by the FDA in 1999.

What is the chemical formula of Rapacuronium?

Rapacuronium has the molecular formula C37H61N2O4+ and a molecular weight of 597.90 g/mol.

Sources

• DrugCentral drug card 3520 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1200549 — compound record and bioactivity
• PubChem CID 5311399 — chemical identifiers
• DrugBank DB04834 — drug record
• FDA UNII GG1LBM463S — substance identity
• DailyMed: FDA labels for Rapacuronium — current prescribing information (label search)

How this page is built: methodology · editorial policy & corrections.